The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.50
Bid: 294.00
Ask: 295.00
Change: 5.50 (1.90%)
Spread: 1.00 (0.34%)
Open: 293.00
High: 300.50
Low: 293.00
Prev. Close: 290.00
IHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

17 Jan 2023 07:00

RNS Number : 8939M
IntegraFin Holdings plc
17 January 2023
 

LEI Number: 213800CYIZKXK9PQYE87

 

 

17 January 2023

 

 

IHP Group quarterly update - Q1 of financial year 2023

 

 

 

Group headlines

 

 

· Resilient net inflows to the Transact platform during the quarter of £0.7bn, with gross inflows for the quarter of over £1.4bn.

 

· Continued growth of the Transact platform's adviser and customer base. As at 31 December 2022 there were over 7.6k registered advisers, and c.227k clients using the platform.

 

· Due to the impact of market movements the average daily funds under direction ('FUD') for the quarter was £51.5bn, whilst in the comparative quarter of FY22 it was £53.5bn.

 

· Cost guidance for financial years ending 30 September 2023 and 30 September 2024 remains unchanged (as issued at our year end reporting in December 2022).

 

 

Transact platform reporting for Q1 FY23:

 

 

 

Quarter ended

31 December 2022

 

 

Quarter ended

31 December

2021

 

 

£m

Opening FUD

50,070

52,112

Inflows

1,469

1,976

Outflows

-769

-688

Net Flows

700

1,288

Market movements

1,319

1,207

Other movements(1)

-26

-68

Closing FUD

52,063

54,539

Average daily FUD for the period (£m)

51,470

53,514

Number of registered advisers

7,632

7,278

Number of platform clients

226,996

213,178

Notes: (1) Includes fees, taxes and investment income.

Time4Advice

 

· Time4Advice's next generation CURO software is currently live for beta testing with an adviser firm, and the planned roll out to adviser firms will commence in the second half of FY23.

 

 

 

Alex Scott, IHP Group Chief Executive Officer, commented:

 

"I am pleased to report another quarter of solid growth for the Transact platform, maintaining the momentum seen during FY22.

 

Whilst the economic landscape continues to be affected by higher inflation and economic uncertainty, the advised market remains robust, with clients continuing to seek financial advice to implement their financial plans and to mitigate the prevailing economic risks.

 

Net inflows to the Transact platform for this quarter of £0.7bn were resilient, particularly in light of the economic environment, and were in line with the fourth quarter of FY22. Outflows for this quarter remained broadly in line with previous quarters, showing that our clients and their financial advisers continue to use the platform to support their long term financial plans.

 

The Transact platform continues to demonstrate growth with new financial advisers joining the platform and client numbers increasing by over 2.2k during the quarter. This provides a solid pipeline for ongoing growth in FUD.

 

Overall, our business is performing well and we are continuing to execute on our strategy. We remain on schedule to commence the roll out of the next generation CURO software during the second half of FY23. We are resolutely focused on delivering the highest quality customer service which, together with our proprietary platform technology, should position us well for ongoing growth.''

 

 

Transact Platform historical information:

 

£m

Q2

FY21

 

Q3

FY21

 

Q4

 FY21

 

Q1

FY22

 

Q2

FY22

 

Q3

FY22

Q4

FY22

 

 

Q1 FY23

Opening FUD

44,824

46,929

50,310

52,112

54,539

53,500

50,300

50,070

Inflows

2,153

1,994

1,967

1,976

2,092

1,703

1,505

1,469

Outflows

-686

-657

-660

-688

-697

-703

-785

-769

Net Flows

1,467

1,337

1,307

1,288

1,395

1,000

720

700

Market movements

694

2,112

553

1,207

-2,376

-4,152

-927

1,319

Other movements(1)

-56

-68

-59

-68

-58

-48

-23

-26

Closing FUD

46,929

50,310

52,112

54,539

53,500

50,300

50,070

52,063

 

Average daily FUD for the period (£m)

 

45,873

48,677

51,647

53,514

52,551

51,889

52,217

51,470

Number of registered advisers

6,962

7,056

7,161

7,278

7,356

7,469

7,537

7,632

Number of platform clients

201,104

205,532

208,611

213,178

218,787

221,992

224,705

226,996

Notes:

(1)Includes fees, taxes and investment income.

 

 

 

 

Enquiries

 

Investors

 

Luke Carrivick, IHP Head of Investor Relations

+44 020 7608 5463

 

Media

 

Lansons: Tony Langham

Lansons: Maddy Morgan-Williams

+44 (0)7979692287

+44 (0)7947364578

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGPUUCGUPWGMQ
Date   Source Headline
23rd Apr 20241:49 pmRNSDirector/PDMR Shareholding
16th Apr 20247:15 amRNS2nd Quarter Results
22nd Mar 20242:31 pmRNSDirector/PDMR Shareholding
12th Mar 20243:49 pmRNSHolding(s) in Company
7th Mar 20244:45 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSResult of AGM
22nd Feb 20244:21 pmRNSDirector/PDMR Shareholding
30th Jan 20249:31 amRNSDirector/PDMR Shareholding
23rd Jan 20243:27 pmRNSAnnual Report and Notice of AGM
23rd Jan 20241:24 pmRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNS1st Quarter Results
10th Jan 202412:50 pmRNSHolding(s) in Company
8th Jan 20243:33 pmRNSDirector/PDMR Shareholding
5th Jan 20244:10 pmRNSDirector/PDMR Shareholding
22nd Dec 202311:52 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFinal Results
24th Nov 202312:26 pmRNSCFO – commencement date of appointment
22nd Nov 20233:01 pmRNSDirector/PDMR Shareholding
25th Oct 20231:10 pmRNSHolding(s) in Company
24th Oct 202311:35 amRNSDirector/PDMR Shareholding
17th Oct 202310:01 amRNSMajor Shareholding Notifications
17th Oct 20237:00 amRNS4th Quarter Results
22nd Sep 202310:33 amRNSDirector/PDMR Shareholding
23rd Aug 202312:09 pmRNSDirector/PDMR Shareholding
24th Jul 20235:47 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNS3rd Quarter Results
7th Jul 20238:18 amRNSAppointment of Chief Financial Officer
3rd Jul 20232:09 pmRNSDirector/PDMR Shareholding
26th Jun 20235:34 pmRNSDirector/PDMR Shareholding
26th Jun 20232:50 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 20232:03 pmRNSDirector/PDMR Shareholding
12th Jun 20234:41 pmRNSHolding(s) in Company
2nd Jun 20235:30 pmRNSHolding(s) in Company
2nd Jun 20235:23 pmRNSHolding(s) in Company
26th May 20237:00 amRNSHalf-year Report
23rd May 20235:25 pmRNSHolding(s) in Company
23rd May 202311:53 amRNSDirector/PDMR Shareholding
16th May 202312:25 pmRNSHolding(s) in Company
10th May 20233:26 pmRNSHolding(s) in Company
3rd May 20234:20 pmRNSHolding(s) in Company
25th Apr 202311:38 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNS2nd Quarter Results
28th Mar 20233:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:32 pmRNSDirector/PDMR Shareholding
23rd Feb 20235:16 pmRNSResult of AGM
22nd Feb 202310:39 amRNSDirector/PDMR Shareholding
9th Feb 20234:16 pmRNSHolding(s) in Company
31st Jan 202311:45 amRNSDirector/PDMR Shareholding
24th Jan 20235:09 pmRNSDirector/PDMR Shareholding
20th Jan 20239:33 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.